Nashville-based CD­MO nets a $65M Se­ries B to ex­pand fa­cil­i­ty and ca­pa­bil­i­ties

An­oth­er $65 mil­lion is mu­sic to the ears of the team at Au­gust Bioser­vices, a con­tract man­u­fac­tur­er in Nashville.

The com­pa­ny an­nounced the Se­ries B round last week, which will fund equip­ment in a new build­ing ex­pect­ed to open in 2023, ac­cord­ing to CEO Jenn Adams. It was led by Oak HC/FT, the same firm that led Au­gust’s Se­ries A round in Ju­ly 2020.

Au­gust Bioser­vices, a pro­duc­er of ma­te­ri­als such as pre­filled sy­ringes, IV bags and vials, was formed back in 2020 af­ter the ac­qui­si­tion of PMI Bio­Phar­ma So­lu­tions, al­so based in Nashville. Adams said the goal was to build a busi­ness that could “ad­dress the scarci­ty of sup­ply rel­a­tive to ster­ile in­jectable man­u­fac­tur­ing based in the US” and pro­vide a broad range of man­u­fac­tur­ing ser­vices.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

Cambridge, MA, USA